Skip to main content
Rapid Reactions

Unmet Needs Still Persist for Women with Metastatic Breast Cancer

Hatem Soliman, MD
Medical Director of the Clinical Trials Office
Moffitt Cancer Center Tampa, Florida
Despite recent advances in treatment, metastatic breast cancer (mBC) remains one of the leading causes of cancer-related deaths in the United States among women. And the prevalence of mBC has also been increasing. In the United States, almost 170,000 women were estimated to be living with the disease in 2020. Hatem Soliman, MD, from The Center for Women's Oncology at Moffitt Cancer Center, discusses how he manages his patients with metastatic recurrence following first-line therapy.

Related Articles